| Altiratinib |
ALTIRATINIB |
1345847-93-9 |
| GSK 2330672 |
GSK 2330672 |
1345982-69-5 |
| TP0903 |
TP-0903 |
1341200-45-0 |
| CZC-25146 hydrochloride |
CZC-25146 hydrochloride |
1330003-04-7 |
| UNC 0631 |
UNC 0631 |
1320288-19-4 |
| 7-({2-[(1-Methyl-buta-1,3-dienyl)-phenyl-aMino]-pyriMidine-5-carbonyl}-aMino)-heptanoic acid Methyl ester |
7-({2-[(1-Methyl-buta-1,3-dienyl)-phenyl-aMino]-pyriMidine-5-carbonyl}-aMino)-heptanoic acid Methyl ester |
1316216-07-5 |
| PF-4989216 |
4-(4-氰基-2-氟苯基)-2-吗啉-5-(1H-1,2,4-三唑-5-基)噻吩-3-腈 |
1276553-09-3 |
| LY2940680 |
4-氟-N-甲基-N-[1-[4-(1-甲基-1H-吡唑-5-基)-1-酞嗪基]-4-哌啶基]-2-(三氟甲基)苯甲酰胺 |
1258861-20-9 |
| (S)-2-nitro-6-((6-(4-(trifluoroMethoxy)phenyl)pyridin-3-yl)Methoxy)-6,7-dihydro-5H-iMidazo[2,1-b][1,3]oxazine |
TBA-354 |
1257426-19-9 |
| SNS-062 |
SNS062 |
1270014-40-8 |
| ETP-46321 |
CS-2500 |
1252594-99-2 |
| MK-7708 |
MK-7708 |
1254577-24-6 |
| MethanesulfonaMide, N-[5-[4-[5-[[(2R,6S)-2,6-diMethyl-4-Morpholinyl]Methyl]-2-oxazolyl]-1H-indazol-6-yl]-2-Methoxy-3-pyridinyl]-, rel- |
GSK2292767 |
1254036-66-2 |
| GSK-2269557 |
GSK2269557 |
1254036-77-5 |
| G1T28 |
曲拉西利双盐酸盐 |
1977495-97-8 |
| RN486 |
RN 486 |
1242156-23-5 |
| A-893 |
CPD3627 |
1868232-32-9 |
| 2-((3S,5R)-3,5-dimethylpiperazin-1-yl)benzo[4,5]imidazo[1,2-a][1,8]naphthyridine-6-carbonitrile |
2-((3S,5R)-3,5-dimethylpiperazin-1-yl)benzo[4,5]imidazo[1,2-a][1,8]naphthyridine-6-carbonitrile |
1822358-25-7 |
| BDA-366 |
BDA-366 |
1821496-27-8 |
| IRAK4-IN-1 |
1820787-94-7 |
1820787-94-7 |
